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ABSTRACT
Introduction: The Rehabilitation Training (ReTrain)
intervention aims to improve functional mobility,
adherence to poststroke exercise guidelines and quality
of life for people after stroke. A definitive randomised
controlled trial (RCT) is required to assess the clinical
and cost-effectiveness of ReTrain, which is based on
Action for Rehabilitation from Neurological Injury
(ARNI). The purpose of this pilot study is to assess the
feasibility of such a definitive trial and inform its
design.
Methods and analysis: A 2-group, assessor-
blinded, randomised controlled external pilot trial with
parallel mixed-methods process evaluation and
economic evaluation. 48 participants discharged from
clinical rehabilitation despite residual physical disability
will be individually randomised 1:1 to ReTrain (25
sessions) or control (exercise advice booklet).
Outcome assessment at baseline, 6 and 9 months
include Rivermead Mobility Index; Timed Up and Go
Test; modified Patient-Specific Functional Scale; 7-day
accelerometry; Stroke Self-efficacy Questionnaire,
exercise diary, Fatigue Assessment Scale, exercise
beliefs and self-efficacy questionnaires, SF-12, EQ-5D-
5L, Stroke Quality of Life, Carer Burden Index and
Service Receipt Inventory. Feasibility, acceptability and
process outcomes include recruitment and retention
rates; with measurement burden and trial experiences
being explored in qualitative interviews (20
participants, 3 intervention providers). Analyses include
descriptive statistics, with 95% CI where appropriate;
qualitative themes; intervention fidelity from videos and
session checklists; rehearsal of health economic
analysis.
Ethics and dissemination: National Health Service
(NHS) National Research Ethics Service approval
granted in April 2015; recruitment started in June.
Preliminary studies suggested low risk of serious
adverse events; however (minor) falls, transitory
muscle soreness and high levels of postexercise
fatigue are expected. Outputs include pilot data to
inform whether to proceed to a definitive RCT and
support a funding application; finalised Trainer and
Intervention Delivery manuals for multicentre
replication of ReTrain; presentations at conferences,
public involvement events; internationally recognised
peer-reviewed journal publications, open access
sources and media releases.
Trial registration number: NCT02429180;
Pre-results.
INTRODUCTION
Residual physical disability is common follow-
ing discharge from stroke rehabilitation ser-
vices. A third of first-time stroke survivors
remain physically disabled 5 years after their
stroke,1 equivalent to more than 300 000
people in the UK (ref. 2, p. 51). Stroke ser-
vices are traditionally ‘front loaded’ with pro-
vision tailing off a few months after stroke.3
However, people with stroke report a variety
of unmet long-term needs and a sense of
being abandoned by National Health
Services (NHS).4 The England National
Stroke Strategy recommends that stroke be
regarded as a long-term condition and that
continuing support is provided for those who
need it.5 This includes community-based
rehabilitation, with an emphasis on
Strengths and limitations of this study
▪ This pilot randomised controlled trial study
meets the Medical Research Council (MRC) guid-
ance on the development and evaluation of
complex interventions and includes comprehen-
sive patient and public involvement.
▪ This preliminary evaluation of a late stage
rehabilitation programme addresses the gap in
the evidence related to what facilitates stroke
recovery in the longer term.
▪ This small scale study is designed to estimate
effect sizes but has insufficient statistical power
to detect differences in outcomes between
groups.
▪ The follow-up period is relatively short compared
with what would be planned for a fully funded
definitive trial.
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personalisation, reablement and self-management of the
consequences from stroke.5 There is good evidence that
exercise can promote functional recovery,3 enhance
adjustment and coping,6 improve psychological well-
being,6 and reduce the risk of recurrence.7 Hence,
stroke guidelines recommend that people with stroke
should regularly engage in specific forms of exercise;8 9
however, many individuals do not meet these recom-
mendations.10 11 Various personal and environmental
factors may account for this: stroke-related impairments,
lack of confidence or knowledge regarding exercise and
its benefits, and inadequate provision of support pro-
grammes and facilities. In response, community-based
programmes are being offered;12–14 however, these pro-
grammes often focus on fitness rather than function,
giving little attention to self-management or to sustain-
ing behaviour (to ensure benefits are maintained after
structured programmes have ended). National stroke
guidelines8 recommend interventions address functional
improvement15 and self-management16 strategies even
though a recently updated Cochrane review17 notes the
gap in evidence regarding these interventions.
An approach called Action for Rehabilitation from
Neurological Injury (ARNI) attempts to address these
concerns; it was created specifically for people with
stroke and acquired brain injury who wish to continue
their functional recovery.18 ARNI is not a rigidly defined
programme but a set of principles and strategies tailored
to individual circumstances and contexts. It is led by
registered exercise professionals who have been
additionally trained and accredited by the ARNI
Institute (http://www.arni.uk.com). Our research
into ARNI started because a stroke survivor participating
in PenCLAHRC’s (http://clahrc-peninsula.nihr.ac.uk/)
research question generation process asked if ARNI
worked but, as yet, there have been no randomised con-
trolled trials (RCTs) of this intervention. In the UK, the
NHS, some local authorities and other organisations are
using ARNI trainers to provide community-based train-
ing for stroke survivors. We surveyed known providers of
this training including those located in Northeast
England, Lancashire, Luton and Bedfordshire, Milton
Keynes, Hillingdon and Cornwall. The survey found that
training has been very positively received by stroke survi-
vors, their families and clinicians but it varied in content
and delivery (unpublished report: Poltawski, 2011).
Reports of benefits by the broadcaster Andrew Marr
have also increased public awareness of ARNI.19
However, the evidence for ARNI remains largely anec-
dotal, it may only work for a selected few and the
approach is difficult to reproduce. There is a need for a
more detailed cohesive specification of ARNI that could
be rigorously evaluated and replicated. Thus, we have
followed the Medical Research Council’s framework for
the development and evaluation of complex interven-
tions20 and have undertaken five linked preliminary
studies: (1) the aforementioned survey of current ARNI
provision in the UK, (2) a comparison of the ARNI
approach with relevant stroke practice guidelines,9 (3)
before-and-after studies of group-based21 and (4)
one-to-one22 training, and (5) focus groups conducted
with our participants.23 From this work we have designed
a programme called Rehabilitation Training (ReTrain)
which is based on core ARNI principles and informed
by best practice guidelines for stroke.9 Before undertak-
ing a large definitive RCT of ReTrain a pilot study is
needed to address issues of feasibility and acceptability.
Aims
To undertake a study that will evaluate the feasibility and
acceptability of procedures to inform the design and
delivery of a definitive RCT of ReTrain (which would
assess the clinical and cost-effectiveness of ReTrain for
stroke survivors). The study objectives are to: (1) assess
the feasibility and acceptability of recruitment, random-
isation, allocation concealment and outcome assessment
blinding procedures; (2) obtain an estimate of the
outcome variance and retention rates to inform sample
size calculations for a fully powered trial; (3) confirm
the feasibility of ReTrain, its acceptability to participants
and finalise the ReTrain Trainer and Intervention
Delivery manuals; (4) assess outcome measurement
burden for participants to confirm that data can be col-
lected (including safety data), measures will be com-
pleted and to inform selection of primary and
secondary measures for the definitive trial; (5) rehearse
process evaluation methods for the definitive trial,
including assessment of intervention fidelity (ie, adher-
ence to the intervention manual by participants and trai-
ners); (6) evaluate resource use, including carer
support, and costs associated with intervention delivery,
assess the feasibility of collecting health and social
service resource use and explore the relative strengths of
measures uses to calculate health-related quality of life
(quality-adjusted life years, QALYs) and provide an eco-
nomic evaluation framework for the definitive trial.
METHODS AND ANALYSIS
Design
A two-group, assessor-blinded, randomised controlled
external pilot trial with parallel mixed-methods process
evaluation and economic evaluation. Eligible partici-
pants will be individually randomised 1:1 to intervention
(ReTrain) or control (exercise advice booklet).24 The
design is depicted in figure 1, which shows the flow of
one cohort of participants (the study comprises three
programmes).
Population
Potential participants will be included if they meet the
following inclusion and exclusion criteria: they have (1)
a primary clinical diagnosis of stroke (assessed by refer-
ring clinician/general practitioner (GP) records), (2)
they are at least 1 month (but no upper limit) since dis-
charge from NHS physical rehabilitation services at
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randomisation, (3) they are able to walk independently
indoors with or without mobility aids, but have self-
reported difficulty with or require help on stairs, slopes
or uneven surfaces, (4) a willingness to be randomised
to either control or ReTrain and to attend the training
venue, (5) have cognitive capacity and communication
ability sufficient to participate in the study (assessed by
recruiting team using standard tools).25
Criterion (3) has been selected pragmatically to maxi-
mise eligibility while ensuring participants have a mobil-
ity deficit that could be addressed by the intervention.
Eligible people with aphasia will not be excluded.
Potential participants will be excluded if they are
<18 years old, currently (or within 1 month of) receiving
ARNI-based training or have contraindications to
moderate-to-vigorous physical activity (adapted from
American College of Sports Medicine (ACSM) guide-
lines)26 including:
▸ Acute or uncontrolled heart failure;
▸ Unstable or uncontrolled angina;
▸ Uncontrolled cardiac dysrhythmia causing symptoms
or haemodynamic compromise;
▸ Symptomatic severe aortic stenosis;
▸ Current deep vein thrombosis, pulmonary embolus
or pulmonary infarction;
▸ Acute myocarditis or pericarditis;
▸ Suspected or known dissecting aneurysm;
▸ Unstable/uncontrolled blood pressure;
▸ Systolic blood pressure >160;
▸ Diastolic blood pressure >100;
▸ Acute systemic infection;
▸ Uncontrolled diabetes.
Sample size
The target recruitment number is 48 participants (24
per group). This number is based on the recommenda-
tion of 30 complete data sets for pilot studies in order to
estimate outcome variance27 and running the interven-
tion three times (Exeter I and South Devon, then
Exeter II, ie, 3×8 patients) to enable investigation of var-
iations in context and other process variables. This
recruited number also allows estimation of a predicted
attrition rate of 20% with a precision of ±5% with 95%
certainty.
Participant recruitment
Participants will be recruited and the programme deliv-
ered in two areas of Devon (Exeter and South Devon).
These areas cover a population of 250 000 with at least
3000 stroke survivors who require the help of others in
everyday activities.11 To maximise potential recruitment,
several routes for recruitment will be used to reach both
those who are just leaving rehabilitation services and
those who have been discharged for some time:
1. Via clinicians in NHS primary care, hospital and com-
munity stroke services:
▸ Early supported discharge teams;
▸ Community rehabilitation teams;
▸ Physiotherapy outpatients departments;
▸ Those responsible for conducting the 6-month
review recommended by the National Stroke
Strategy;
▸ GP surgeries via the local Clinical Research
Network (CRN).
Clinicians will provide potential participants with an
invitation letter and brief description of the study and, if
they are interested, obtain permission to pass on their
details to the study team. The clinician will ask the
potential participant to complete a short form (or com-
plete the form on their behalf), recording their contact
details and consenting for these details to be passed to
the research team.
Figure 1 Study flow chart.
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2. Direct (using contacts)
▸ The CRN (formerly South West Stroke Research
Network (SW SRN)) using hospital-based recruitment
team, newsletters and targeted mailing;
▸ Exeter Clinical Research Facility which maintains a
database of health research-interested members of
the public;
▸ Letters, articles and posters will be used to provide
brief details of the study and invite expressions of
interest to contact the research team by telephone
call, email or post.
3. Promotion via local stroke support networks identi-
fied through national organisations such as the
Stroke Association, Different Strokes and Connect,
and via internet searches and in local media.
4. Word of mouth, study flyers, adverts and information
sheets.
We have discussed recruitment plans with two local
community rehabilitation team leads and the CRN (who
have checked three GP surgery’s databases); from this
we estimate a recruitment rate of 5–6 participants per
month although this is one of the feasibility objectives
being tested in this study. Our preliminary Devon-based
studies recruited 2–4 participants per month, but only
from the Exeter area, without formal network support,
using fewer routes, and based on narrower inclusion cri-
teria to the current proposal.
A potential issue in recruitment is the likelihood of
attracting people who are already committed to exercise
and not those who are currently inactive, who may be
put off by the emphasis on the term ‘exercise’. Focus
groups conducted previously by the research team, and
our Service User Group (SUG), have suggested that pro-
motion should emphasise the potential functional and
quality of life benefits, and not promote it primarily as
physical exercises. To this end, a member of the research
team will brief and support the personnel involved in
providing initial information about the study to potential
participants, and where necessary spend time in contact
with potential participants to help their understanding
of the intervention and study. For those who are already
committed to exercising, they will still be eligible provid-
ing they are no longer involved in a formal rehabilita-
tion programme. Because of uncertainty in recruitment
rates and patterns and the need to have eight people
ready to start the training programme, some participants
may have to wait several weeks until sufficient group
members have been recruited. To help mitigate the
potential problem of excluding those who do not live
close to a venue, reasonable travel costs (eg, mileage
claims, local bus and train journeys, and specialised
wheelchair taxis) to and from the training venue will be
offered to all participants.
Randomisation and group allocation
To ensure allocation concealment, participants will be
allocated 1:1 to either intervention or control arms
using a web-based randomisation service supported by
the Peninsula Clinical Trials Unit (PenCTU). We will use
minimisation procedures to ensure balance between
groups on two variables: time since stroke (≤3 vs >3
months), since spontaneous recovery might be more
likely among those whose stroke was relatively recent,28
and level of functional disability (modified Rankin
Scale29 (mRS) score ≤2 vs >2), since this may limit the
extent and nature of training possible for a participant.
Once the remote randomisation service has registered
and randomised the participant, allocation will be made
known to the trial manager, who will not be involved in
assessing patient outcomes. Following randomisation,
the trial manager will contact participants to inform
them of group allocation.
Blinding
Participants, personal trainers providing the interven-
tion, and researchers conducting the process and eco-
nomic evaluation cannot be blinded to allocation.
However, outcomes will be assessed by an independent
assessor blinded to group allocation. Participants, who
have been informed of their allocation, will be reminded
to hide their allocation from the assessor. Any incidents
of unblinding will be recorded, and the assessor will be
asked to record their guess of participant allocation
after undertaking the assessments. Following recom-
mended strategies to maintain and assess blinding,30 the
outcomes assessor will not be based at the research
centre.
Intervention
ReTrain is a specified intervention that is based on
ARNI but also draws on poststroke exercise guidelines,9
our preliminary studies and stakeholder consultations;
this combination makes it a novel intervention com-
pared with other community exercise-based pro-
grammes. ReTrain aims to (1) enhance function
through (A) task-related practice, (B) teaching adapted
or compensatory strategies and (C) provide targeted
strength training (cardiovascular physical fitness gains
also occur through these activities); (2) develop self-
management skills for ongoing rehabilitation; (3) per-
sonalise training using negotiated goals; and (4) instil a
commitment to and habit of regular exercise for health
improvement and longer term maintenance (once struc-
tured training programme has been completed).
ReTrain focuses on functional mobility which includes
safe and efficient walking in varied terrains, kerbs,
cambers and in crowds, turning and moving quickly,
climbing steps and stairs without rails, getting to and
from the floor without furniture or other aids, and
moving about without mobility aids or while carrying
loads. Training will be based on an Intervention Delivery
manual and led by personal trainers on the Register of
Exercise Professionals (level 3 or above) who are
ARNI-trained and accredited (and will be aware if there
are stroke-related concerns that require referral) and
they will have received additional training in the delivery
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of ReTrain. There will be a maximum ratio of one
trainer to four stroke survivors. The use of personal trai-
ners rather than clinicians is based on a principle of
de-medicalising the rehabilitation process18 31 32 and
received strong support from our SUG. It may also have
cost-effectiveness benefits.14 33 ReTrain is predominantly
based in a community centre with twice weekly, 90 min
sessions over 3 months, comprising: (1) an introductory
one-to-one session (as a home visit); (2) group classes
with up to two trainers and eight clients (preserving the
maximum ratio of one trainer to four participants); (3)
a closing one-to-one session (as a home visit). This is fol-
lowed by three drop-in sessions over the subsequent
3 months at the community centre. The final one-to-one
session and monthly drop-in sessions address concerns
raised by our preliminary study participants of the
sudden cessation of support.23 A more thorough descrip-
tion of the intervention can be seen in figure 2. The
ReTrain Trainer and Intervention Delivery manuals were
designed using an overarching theoretical framework
that enabled existing evidence-based components (from
the physiology of exercise training, Behaviour Change
Techniques34 and stroke rehabilitation guidelines) to be
mapped together with the as yet unresearched ARNI
principles and techniques. The theoretical framework is
known as the Information-Motivation-Behavioural Skills
model35 and enables intervention mapping to take
place.36 This mapping process will be developed and
refined as part of the feasibility work of this study and
will specify the essential resources, activities and beha-
viours of trainers and clients that must be present in ses-
sions and across the programme. Session checklists will
capture the main content and indicate where flexibility
is permitted (for individualisation of training) and allow
evaluation of intervention fidelity.
Links between ARNI and ReTrain
The ARNI principles were identified through analysis of
ARNI documentation,18 discussion with its developer
and the survey of existing ARNI programmes. Although
ARNI aims to address all aspects of function, the
ReTrain programme focuses on functional mobility
because of its association with independence in activities
of daily living and social participation. ARNI provides
strategies for developing these skills that have been
adapted for people with hemiplegia and other
stroke-related impairments. ReTrain will not focus on
upper limb function except in the service of such mobil-
ity tasks.
ARNI aims to enhance individual’s ability to manage
their own rehabilitation and exercise programme. This
is achieved through a variety of strategies and techniques
including education in exercise principles after stroke,
developing skills in goal setting, functional problem
solving and self-monitoring, and establishing a pro-
gramme of regular independent home-based exercise.
ReTrain will ensure that these activities are incorporated
into the training process.
ARNI is designed as a personalised programme with
substantial one-to-one training to ensure individual tai-
loring of activities, feedback and progression, and
encouragement to work at the edge of personal capacity.
The ReTrain programme combines these features with
the benefits of a group programme which include peer
support, pair work and efficient use of resources.22 23
The structure of the ReTrain programme is described in
figure 2, and a more detailed Intervention Delivery
manual will be developed and refined as part of the
study.
Control
All participants receive treatment as usual (which will be
recorded for both groups) however, in addition, the
control group will receive an advice booklet about exer-
cise after stroke, based on a Stroke Association’s publica-
tion.24 This offers a low-cost alternative to ReTrain that
might be provided to stroke survivors, although it does
not give advice on specific exercises. We believe offering
an advice booklet to the control patients, will improve
recruitment and retention.
Assessment and outcomes
Initial screening assessment
Those expressing an interest in taking part in the study
will be contacted by telephone by a member of the
research team and, with their permission, be asked ques-
tions to assess their eligibility. These will address: diagno-
sis of stroke, time since stroke, status regarding receipt
of poststroke physical rehabilitation, mobility, potential
contraindications to exercise and willingness to exercise
regularly as part of intervention but also willingness to
be in the control group. Permission will be sought to
contact the person’s GP (and/or referring clinician, if
this is the recruitment route) to obtain relevant medical
history and screen for contraindications. This verbal
consent will be documented. A medical screening ques-
tionnaire will be sent to the GP if the person appears eli-
gible for inclusion in the study. The research team will
await receipt of the completed GP letter but will contact
the practice after 7 days if there has been no reply from
the GP. Once the GP letter has been received by the
research team, those potentially eligible will be con-
tacted to arrange a home-based visit. Those not eligible
will be thanked and informed of the ineligibility.
Home-based screening and data collection
Those apparently eligible for inclusion will be visited at
home by a member of the research team to provide
further information about the intervention and study,
and to obtain written consent. There are discrete activ-
ities within the trial that require specific consent from
the participant. As part of the consent process partici-
pants will be asked whether they would be willing for a
researcher to look at their medical records to view the
number of primary and secondary care resources they
used over the course of the trial. They will also be asked
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whether they would like to take part in an interview at
the end of the trial to discuss their experiences.
Participants will also be asked whether they would be
happy to be video-recorded during some training ses-
sions, should they be allocated to the ReTrain
programme. All participants will be asked their consent
again immediately prior to these activities so that they
can confirm or decline consent.
Demographic and other personal information will also
be collected at this time:
Figure 2 The ReTrain programme. (ARNI, Action for Rehabilitation from Neurological Injury; GP, general practitioner; TM, trial
manager).
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▸ Date of birth, gender;
▸ Stroke history (type, severity, date, summary of
rehabilitation);
▸ mRS score, established by a simple questionnaire;29
▸ Medical history (comorbidities, current treatments);
▸ Social history (employment status, previous employment);
▸ Physical exercise history (prestroke, poststroke, last
month: type, frequency, intensity).
Depending on recruitment patterns, those eligible
and consenting may be required to wait several weeks
before start of the intervention. They will be kept
informed of timings by a member of the research team.
Clinical outcomes
We will collect both the objective physical outcome and
participant-reported outcome measures (PROMs) that
we intend to collect in a definitive trial. Outcome selec-
tion was informed by discussions with our SUG and data
from our preliminary studies. The measures are: the
Rivermead Mobility Index;37 38 the Timed Up and Go
Table 1 Trial outcome measures and when used (1=baseline; 2=postintervention; 3=follow-up)
Measure
Time to administer Assessment
(mins) 1 2 3
Primary
Rivermead Mobility index37 38
15-item, dichotomously scored measure of mobility disability. 14 items are
self-report and 1 (standing for 10 s without aids) is scored by observation.
5 ✓ ✓ ✓
Timed Up and Go Test39
Objective measure of mobility, balance and locomotor performance, in which the
individual is observed and timed rising from a chair, walking 3 m, turning and
returning to the chair
5 ✓ ✓ ✓
Modified Patient Specific Functional Scale40*
Identification by individual of up to 5 functional tasks that are important and
difficult to perform, and rating of ability to perform each task on a 0–10 scale
10 ✓ ✓ ✓
Physical Activity Diary*
Participants record the type of activity and its duration each day of the week
(1–2 min/day to complete)
10–15 ✓ ✓ ✓
Physical activity—7-day accelerometry41
Worn by individual to assess physical activity behaviour over 7 days. Should take
5 min to fit watch and 10 min to post back
15 ✓ ✓ ✓
Secondary
Fatigue Assessment Scale43 44*
10-item self-completion questionnaire in which aspects of fatigue are rated on
how regularly they are experienced, using a 5-point scale
5 ✓ ✓ ✓
Stroke Self-efficacy Questionnaire42*
10-item questionnaire in which participants rate their confidence in completing
some tasks that may have been difficult for them since their stroke
5 ✓ ✓
Exercise beliefs questionnaire45*
Measures attitudes to exercise by rating levels of agreement to 5 statements
about what it can achieve for the individual
3 ✓ ✓
Exercise self-efficacy questionnaire45*
Self-rating of confidence to overcome 4 personal barriers to exercise
3 ✓ ✓
Stroke Quality of Life48 49*
Self-rating of 12 dimensions of lifestyle and personal functioning
5 ✓ ✓
EQ-5D-5L47*
Measuring health-related quality of life and can be used for cost-utility analysis
3 ✓ ✓
SF-1246*
Abbreviated version of the Short-Form-36 self-completion questionnaire
measuring health-related quality of life. It can also be used to calculate the
SF-6D, which may be used for cost-utility analysis
5 ✓ ✓
Service Receipt Inventory51*
Record of types and amount of use of health and social care resources including
medication, clinical contacts, formal and informal social care. Completed by
assessor drawing on participant and family accounts, and clinical records if
available
10 ✓ ✓
Carer Burden Index50*
Carers of stroke survivors rate the difficulties and challenges of providing care
5 ✓ ✓
Adverse incidents52 3 ✓ ✓
*Questionnaire may be mailed for self-completion before home visit or left after a research team visit.
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Test;39 a modified Patient-Specific Functional Scale;40
7-day accelerometry41 (using the GENEActiv which is
waterproof, can be continuously worn and programmed
to start and stop automatically, see http://www.geneactiv.
co.uk); the Stroke Self-efficacy Questionnaire,42 physical
exercise levels assessed by physical activity diary, the
Fatigue Assessment Scale,43 44 exercise beliefs and exer-
cise self-efficacy questionnaires,45 the SF-12,46 the
EQ-5D-5L47 and Stroke Quality of Life questionnaires48 49
and the Carer Burden Index.50 Health and social service
use will be measured through a Service Receipt
Inventory.51 The PROMs and instructions for their com-
pletion will be collated into a booklet.
Baseline assessments will be done by a member of the
research team. Physical outcome follow-up assessments
(at 6 and 9 months) will be conducted at the partici-
pant’s home, by a blinded assessor trained in all elements
of the assessment procedure. Self-report questionnaires
for 6-month and 9-month follow-ups will be compiled
into a single booklet with instructions for completion,
and mailed to participants along with the accelerometer
and a physical activity diary, a week before the home visit,
unless participants request a visit from a member of the
research team to help fit the accelerometer. If materials
are posted, prior to each blinded assessor visit a member
of the research team will call the participant to check
that they are still available to meet. During this call the
member of the research team will check how the partici-
pant is progressing with the questionnaire and check
whether the accelerometer is still being worn and is com-
fortable. Participants will also be asked to report any
adverse events, enquiring explicitly about whether they
have experienced any fatigue, muscle soreness or falls
(all expected adverse events). If materials are delivered
by a member of the research team, the accelerometer will
be fitted, adverse event report taken and questionnaire
booklets left for completion. The blinded assessor will
check questionnaires for completeness and understand-
ing during their visit. Table 1 indicates the outcome
instruments and the time points for their use.
Feasibility, acceptability and process outcomes
The feasibility of a definitive RCT will be determined by
collecting and analysing the following pilot study data.
The numbers and details of those approached; the
recruitment and retention rates, as well as recruitment
patterns from each route and geographical area. Those
who decline to participate or drop-out of the study will
be invited to participate in a brief phone interview
regarding their reasons. Acceptability of randomisation,
outcome measurement burden, interventions and other
aspects of trial participation will be investigated by
checking completion of questionnaires and objective
assessments as well as through interviews with 10 inter-
vention and 10 control group members (purposively
selected to ensure inclusion of different genders, ages,
disability levels and previous exercise experience) and
by postintervention interviews with the trainers. These
qualitative interviews will use a semistructured interview
schedule designed to cover the above issues as well as
ask about other personal and contextual factors that
may affect participation and outcomes (ie, barriers and
facilitators) including what refinements might be
needed for the definitive trial delivery. Interviews will be
conducted by a member of the research team at a con-
venient time and location for the participant after the
intervention period. Adverse events will be identified,52
via trainer reports and the research staff explicitly ques-
tioning participants, using trial standard operating pro-
cedures. No serious adverse events were reported in the
preliminary studies. Intervention fidelity will be assessed
by several methods: attendance, accelerometry, exercise
diaries, session checklists and video analysis of selected
training sessions in each programme.
Usual care
Participants in intervention and control arms may
receive health and social care as part of their usual care,
and these will be recorded using the Service Receipt
Inventory.
Foreseen difficulties
(1) ‘Exercise’ as a term may be off-putting to some
people. Our SUG and preliminary studies participants
strongly advised that we emphasise the potential func-
tional and quality of life benefits and not promote
ReTrain as an exercise programme; however, it was
agreed that community leisure centres were an accept-
able venue. (2) Timing: some of those who give consent
to take part may have to wait until the next ReTrain pro-
gramme is ready to start. The wait will be minimised by
running successive Exeter-based programmes alongside
the South Devon programme and the study team will
maintain brief but regular contact with those waiting.
The feasibility and acceptability of this process, includ-
ing the wait time and recruitment/retention issues more
generally, are part of what is being tested in this pilot
study. (3) Participant burden: particularly completion of
the battery of measures and travel to intervention venue.
These were deemed acceptable by most participants in
our preliminary studies and this was affirmed during our
SUG events when planning this proposal. Participant
carers may experience some burden as they may need to
support the participants by providing travel to and from
the 23 training sessions at the community centre venue.
The carer will also be asked to complete a questionnaire
at two time points during the research. (4) Trainer avail-
ability: we worked with five trainers during our prelimin-
ary studies and there are currently more than 100
accredited ARNI trainers in the UK, indicating there
would be capacity to deliver a future multicentre trial
but more trainers might be needed if wider future
implementation was indicated. Three local trainers have
agreed to deliver the current study ReTrain
programmes.
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Service user involvement
Stroke survivors, their partners and carers have been
consulted at all stages of the work leading to this pro-
posal. In 5 SUG events and 14 research development
meetings over 5 years our patient and public involve-
ment (PPI) representatives have materially influenced
decisions on the study population, promotion and
recruitment, the nature of the ReTrain intervention and
how its effectiveness should be assessed. One experi-
enced PPI representative will be in the Trial
Management Group (TMG), and another, who has
experience of ARNI training, will be in the Study
Advisory Group (SAG). The founder of ARNI, Dr Tom
Balchin will also be part of the SAG. Our service users
will also continue to contribute throughout this pilot
study in terms of reviewing documentation for ethics
approval, commenting on and proof reading reports
and contributing to dissemination activities. They have,
and will continue to be, supported in their work by the
Peninsula’s Collaboration for Leadership in Applied
Health Research and Care (PenCLAHRC) PPI team, for
example, by attending workshops on critical appraisal
skills.
Data analysis
Given the feasibility objectives of this pilot study, the
focus of data analysis will be descriptive. For both
recruitment settings (Exeter and South Devon) partici-
pant flow will be summarised using the CONSORT flow
diagram, reporting recruitment and attrition rates (both
treatment and study drop-outs) with 95% CIs. The
diagram will also reflect the number of recruitment
letters sent, numbers consenting, number randomised,
number undertaking intervention and number of com-
pleted outcomes alongside means and SDs regarding
the number, length and frequency of sessions. All proto-
col deviations, along with reasons and number of
missing items on questionnaires will be reported. Mean
and SDs (or equivalent) for all clinical outcomes for
both study arms will be reported at baseline, 6 and
9 months follow-up. For the trial process evaluation, we
will use a thematic analysis for the qualitative interview
data and use several of the quantitative measures
(including demographic, medical and questionnaire
data) to help identify and understand potential media-
tors and moderators of trial outcome. For the analysis of
intervention fidelity, we will use the procedures we
designed and tested in our preliminary studies for the
video analysis combined with trainer interview data and
the session checklists (that will be part of the
Intervention Delivery manual). These data collection
and analysis methods will be assessed for their potential
to inform the process evaluation component of a defini-
tive trial. In such a future trial, the health economics
analysis will be a cost-utility analysis, using QALYs and
secondary analyses will investigate the benefits of the
intervention more broadly within the framework of a
cost consequences approach, so offering the potential to
weight different outcomes in a multicriteria decision
analysis framework.51 In this pilot study, we will assess
the relative benefits of calculating health-related quality
of life using SF-6D developed from the SF-12 over the
QALY calculated using EQ-5D-5L; explore the psycho-
metric properties of the SF-12 and investigate whether it
has greater ability to discriminate between the milder
health states. We will assess costs associated with inter-
vention delivery as well as assess the feasibility of collect-
ing health and social service resource use through a
Service Receipt Inventory. Any missing data in the
Inventory will be recorded and we will check if any
resource use categories are misunderstood by matching
Inventory completion with medical records for a sub-
group of participants. This will help us develop strategies
to minimise missing data in a future definitive trial.
Study timeline
The timetable for the research can be seen in table 2:
months 0–4 set up and trainer briefing; months 0–9
recruitment: including participant identification (0–9
months), screening (2–9 months), consent and baseline
assessments (3–9 months); months 5–15 training pro-
grammes inclusive of 6 and 9 month follow-ups; month
18 complete the 9-month follow-ups; months 11–18
interviews; months 16–21 analysis and final reports. Trial
management meetings and SUG meetings will be held
on 10 occasions across the 21 months of the study.
Incentives and payments
Incentive payments will also be made to control and
intervention group participants and paid on two occa-
sions: £10 in vouchers at 6 months and £10 in vouchers at
9 months. These incentives are intended to maximise the
chances of obtaining a full data set, including the views of
any people who leave the intervention or control groups
(but do not fully withdraw from the study) and this will
assist the process evaluation. Participants have to remain
in the study but do not have to complete all assessments
in order to receive the vouchers.
The latest NHS Health Research Authority guidance
on Payments and Incentives in Research (May 2014,
Section 9.1) states that pro-rata payments based on the
amount of time completed and/or the number of
research procedures undertaken are legitimate. Our
intention would be to disburse 50% of the incentive
payment at the time of the postintervention (6 months)
outcome assessment and the remainder at the time of
the follow-up (9 month) assessment.
ETHICS AND DISSEMINATION
Ethics
Research and Development (R&D) approval was
granted from the mid-Devon and Torbay Primary Care
Trusts (1602209). The study will be conducted in accord-
ance with the principles of the International Conference
for Harmonisation of Good Clinical Practice (ICH GCP)
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guidelines53 and the Research Governance Framework
for Health and Social Care.54 Any amendments to the
trial documents will be approved by the sponsor before
submission to the Research Ethics Committee (REC)
and R&D departments. This is a University of
Exeter-sponsored research study, working in collabor-
ation with NHS trusts. The University’s Clinical Trials
insurance cover provides either legal liability cover or
non-negligent/no-fault compensation cover. Research
passports and letters of access will be acquired for the
Trial Manager and Associate Research Fellow so that
they may visit GP surgeries to extract data during
medical notes review.
Governance and safety considerations
Drafts of the trial protocol have been reviewed by the
Southwest Research Design Service and the Stroke
Clinical Studies Group. The trial is registered with the
ClinicalTrials.gov: trial number NCT02429180. The
study sponsor is the University of Exeter.
Adverse events
In preliminary studies, several falls were recorded,
though none required medical intervention. Transitory
muscle soreness and high levels of postexercise fatigue
were also reported in some cases, but there appears to
be a low risk of serious adverse advents associated with
this intervention. Those providing the intervention are
trained in health and safety procedures and will be
required to ask participants about any adverse events
occurring at home, and record any reported or wit-
nessed during the intervention. Participants will also be
asked about adverse events as part of the process evalu-
ation (to maintain blinding of the outcomes assessor).
Any serious adverse event will be immediately reported
to the trial sponsor and relevant ethics committee if the
chief investigator (CI) deems it related to the interven-
tion, and to the independent Trial Steering Committee
(TSC) members who are also acting as our Data
Monitoring and Ethics Committee.
Trial monitoring and management
Day-to-day running of the trial will be the responsibility
of the trial manager. Standard operating procedures will
be written for: (1) assessment processes and reporting;
(2) data management; (3) adverse incidents monitoring,
reporting and action; (4) study staff health and safety.
The core study team (CI, trial manager and assistant
research fellow) will meet at least fortnightly during the
study. TSC meetings will be held (if necessary by tele-
conference) on three occasions. The TSC will discuss
recruitment, withdrawals, study progress, process evalu-
ation and adverse events, and will advise on protocol
amendments where necessary. The steering group will
include academics with expertise in trial methodology,
health economics, qualitative methods and process
evaluation, clinicians with expertise in stroke and
rehabilitation, and stroke survivors. Owing to the low
risk of adverse events, an independent Data Monitoring
and Safety Committee will not be appointed for this
pilot study. Instead, we will appoint suitably qualified
academics and clinicians to the TSC who will have
responsibility for independently monitoring the safety
and quality of the trial. A closed meeting prior to the
TSC meetings will take place with the independent
members of the TSC who will also be responsible for
oversight of the safety of the trial and data integrity
(thereby taking on the role of the Data Monitoring and
Ethics Committee).
Our preliminary studies suggest that the trial does not
pose any specific risks to individual participants nor
does it raise any substantial ethical issues. Based on
results from our development work ReTrain is a low-risk
intervention. Participants will be informed of possible
benefits and known risks of participation in the trial by
means of a patient information leaflet and discussion
with the research team. All participants will sign a
consent form approved by the Ethics Committee. They
will be consented to participating in the trial, being ran-
domised and followed up, for accessing their medical
records to review their primary and secondary care
resource use, for video-recording of training sessions,
participating in and being audio-recorded during inter-
view and being contacted in the future about this and
other research. Individuals who are not able or not
willing to be randomised will not be recruited.
Individuals will be sent an additional patient informa-
tion leaflet relating to the interview study. Written
consent will be obtained again immediately prior to the
interview study, the video-recorded training sessions, and
prior to medical notes review. This will be performed to
allow the participants to fully consider their participa-
tion decisions and to confirm or change their original
consenting decision.
Table 2 Gannt chart of study timeline
Months 0 1 2 3 4 5 6 7 8 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Set up; brief trainers
Recruitment
Training programmes×3
including 6 months follow-up
Interviews
Analysis and reporting
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Data management
Data will be collected and retained in accordance with
the UK Data Protection Act 1998, and managed in
accordance with the trial-specific standard operating pro-
cedure for data management. With their consent, partici-
pant details will be passed between the NHS and the
research team by telephone or in person (ie, not elec-
tronically via email or text message). All enrolled partici-
pants will be allocated a unique study ID, and the
information linking their ID to their personal details will
be kept securely at the University of Exeter. All other
participant-related paper records will be anonymised and
stored separately from the personal information. The
electronic database for the trial will be stored on the
secure servers of the University of Exeter with password-
controlled access provided for the research team by the
Peninsula Clinical Trials Resource Unit. Single data entry
with extensive in-built validity checks will be used to
reduce the risk of transcription errors. The study data-
base will include prompts for missing data, and warnings
to alert staff when values are entered that are outside of
the expected range or are inconsistent with other data
already entered, or if the type of value entered is incor-
rect (eg, a numeric value entered rather than text).
Video-recordings and audio-recordings will be digi-
tised, encrypted and stored on the university secure
server. Audio-recordings will be retained until after
anonymised transcripts have been finalised and ana-
lysed. At this stage they will be securely and permanently
deleted. Access to personal data will be restricted to the
research team. Names and participant details will not be
passed onto any third parties and no named individuals
will be included in the write up of the results.
All participants (stroke survivors and personal trai-
ners) will be asked for their consent for the study team
to retain interviews and video-recordings for the pur-
poses of future research by those involved directly in the
study team or for educational purposes.
All study data will be kept for 10 years under secure
conditions on University of Exeter secure servers. Data
will also be subject to standard secure storage and usage
policies.
Dissemination and impact activities
Trial progress will be reported to our SUG quarterly. At
the end of the study, we will seek input from our SUG to
help disseminate a lay summary of the findings to study
participants. A trial publication policy will be developed.
We envisage a number of key papers arising from this
pilot trial. The publication policy document will outline
the strategic plan for dissemination. The results of the
trial will be reported first to study collaborators and to
the funder (the Stroke Association). The sponsor and
funder play no role in the study design, conduct, ana-
lyses, data interpretation or report writing. The funder
requires advance notification of any planned public dis-
semination activities but does not hold authority over
these activities. The main report will be drafted by the
TMG and circulated to all collaborators for comment.
The final version will be agreed by the TSC before sub-
mission for publication, on behalf of all the ReTrain col-
laborators. We will report to our objectives and hold
meetings with our TSC, TMG and SUG to discuss
whether we have a sufficient case to apply for funds to
run a definitive RCT of ReTrain.
Key outputs from the trial will contribute to our dis-
semination and impact agenda: (1) pilot data will
inform the decision whether to proceed to a definitive
RCT and if so we will have (2) the evidence to support a
funding application and (3) finalised Trainer and
Intervention Delivery manuals to enable multicentre
replication of ReTrain; (4) presentations at national and
international conferences, seminars and PPI events and
(5) dissemination through internationally recognised
peer-reviewed journal publications (including open
access web sources), newsletters and media releases.
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